Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17445781 | 0.79 | TSHR (0.42) | TSHRTP53TDP1PPARDCA1 | |
| SCHEMBL2855157 | 0.79 | TSHR (0.50) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL14141773 | 0.78 | PPARD (0.39) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL8714812 | 0.77 | TSHR (0.48) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL8623480 | 0.72 | TSHR (0.36) | TSHRTP53TDP1PPARDCA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL19812734 | 0.71 | TSHR (0.43) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL22829580 | 0.71 | TSHR (0.39) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL8764678 | 0.70 | — | — | |
| Triethyl Phosphate SCHEMBL27295346 | 0.70 | TSHR (0.72) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL22829573 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5712396-A | PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS | MAGNIN DAVID R (US) | 1998-01-27 | — | — | US | disclosed |
| US-5567841-A | ANTICHOLESTEROL AGENT | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-10-22 | — | — | US | disclosed |
| US-5470845-A | Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-11-28 | — | — | US | disclosed |